UltraSound - Technology Information PortalTuesday, 28 February 2017
Info
  Sheets



Out-
      side
 




 
 US Database 
SEARCH FOR   
  12345ABCDEFGHIJKLMNOPQRSTUVWZ
1 - 5 (of 21)     next 
iE-Im     Im-In   In-In   In-Is   iU-iU   
 bottom
spacer
Radiology Database Open this link in a new window Magnetic Resonance Imaging Database Open this link in a new window
spacer
US Resources  
Education pool - Obstetric - UltraSound Training Courses - Examinations - - Breast
 
iE33InfoSheet: - Systems -
Intro, 
TypesMRI Resource Directory:
 - Devices Machines Scanners Systems -
 
www.medical.philips.com/main/products/ultrasound/cardiology/ie33/index.html

From Philips Medical Systems;
'Introducing the iE33 echocardiography system.
The iE33 is a 3D quantitative echo system that will change the way echo exams are performed. Intelligent design and intelligent control combine to bring you revolutionary clinical performance and workflow.'

Specifications for this system will be available soon.

spacer

• View the NEWS results for 'iE33' (1).Open this link in a new window.

• View the DATABASE results for 'iE33' (2).Open this link in a new window.

 Further Reading:
  Basics:
iE33 Product DescriptionOpen this link in a new window
   by www.healthcare.philips.com    
Image QualityInfoSheet: - Artifacts -
Intro, 
Artifacts, 
ReductionMRI Resource Directory:
 - Artifacts -
 
The perfect image quality is dependent on some assumptions of the propagation of ultrasound waves in tissues after generating in an imaging system. These assumptions are important for the developing of optimal ultrasound imaging systems.
point The sound velocity in the examined tissue is homogeneous and constant (around 1540 m/s).
point The propagation of ultrasound is straight ahead.
point The ultrasound beam is infinite thin in its thickness and lateral direction.
point The detected echo comes from the shortest sound path between reflector and transducer.
point The ultrasound echo is originated by the last generated sound pulse.
point The amplitudes of the echoes are proportional to the difference of the acoustical impedance caused by different tissue layers.
A lot of steps can be taken to prevent artifacts and to improve image quality, for example beamforming is used to focus the ultrasound beam, and contrast agents decrease the reflectivity of the undesired interfaces or increase the backscattered echoes from the desired regions.
See also Coded Excitation, Validation and Refraction Artifact, Q-Value, Ultrasound Phantom, Dead Zone, Narrow Bandwidth.
spacer

• View the NEWS results for 'Image Quality' (8).Open this link in a new window.

• View the DATABASE results for 'Image Quality' (35).Open this link in a new window.

 Further Reading:
  News & More:
Guidelines for the Safe Use of Diagnostic Ultrasound(.pdf)Open this link in a new window
   by folk.ntnu.no    
Real-time B-mode ultrasound quality control test procedures a Report of AAPM Ultrasound Task Group No. 1Open this link in a new window
   by www.aapm.org    
US Resources  
Modes - Jobs - DICOM - Cardiac - Developers - General
 
Imagent®InfoSheet: - Contrast Agents -
Intro, 
Historical Development, 
Microbubbles,
etc.MRI Resource Directory:
 - Contrast Agents -
 
Imagent® is an injectable suspension for intravenous administration during a sonogram. This diagnostic contrast agent for enhancement of ultrasound images contains perflexane lipid microspheres. Imagent® US is indicated in the assessment of heart function and perfusion, as well as the detection of tumors and blood flow abnormalities by using gray scale, color Doppler, and harmonic ultrasound imaging techniques.
During the course of its development, the brand name for this product has changed from Imagent to Imavist (between August 2000 and March 2002) back to Imagent. The manufacturer's 06/03/02 press release announcing FDA approval refers to the product as "Imagent (formerly Imavist)," and the approval notice and monograph posted at the FDA site refers to the product as Imagent.
Jointly developed by Alliance Pharmaceutical Corporation and Schering AG (Germany). Source: PR Newswire - 10/10/96, 03/31/98, 10/13/99, 03/13/01, 10/08/01; FDA approvals - 05/31/02; Alliance Pharmaceutical press release - 06/03/02.

Drug Information and Specification:
RESEARCH NAME AF0150
DEVELOPER IMCOR Pharmaceuticals, Inc.
INDICATION -
DEVELOPMENT STAGE
Echocardiography
APPLICATION Intravenous
TYPE Microbubbles
SHELL Lipid: DMPC
CHARGE Neutral
GAS Perfluorohexane/Nitrogen
MICROBUBBLE SIZE 99.8% < 10µm
PRESENTATION -
STORAGE Room Temp 15–30°C
PREPARATION Reconstitute with 10 ml water
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!

Distribution Information:
TERRITORY DISTRIBUTOR
USA, EU Bristol-Myers Squibb Medical Imaging, Inc.

spacer

• View the DATABASE results for 'Imagent®' (3).Open this link in a new window.

 Further Reading:
  Basics:
CONTRAST ECHOCARDIOGRAPHY: NEW AGENTSOpen this link in a new window
   by eurheartj.oxfordjournals.org    
  News & More:
The role of ultrasound in molecular imaging(.pdf)Open this link in a new window
2003   by bjr.birjournals.org    
IMCOR Pharmaceutical Co., Alliance Pharmaceutical Corp., Molecular Biosystems, Inc. and GE Healthcare Ltd., Inc. Enter Into Cross-Licensing Agreement for Ultrasound Contrast PatentsOpen this link in a new window
   by www.prnewswire.com    
ImagicInfoSheet: - Systems -
Intro, 
TypesMRI Resource Directory:
 - Devices Machines Scanners Systems -
 
kontron2004.veloce-it.net/

From Kontron Medical SAS;
Sigma 5000 Series
'THE ADVANCED VISION
With the ability to continuously evolve over time for unprecedented return on investment, Imagic, Sigma 5000 Series, is the 2004 breakthrough in the ultrasound field.
The all digital platform coupled with some proprietary technologies and a high quality, extra-large flat TFT monitor, display state-of-the-art image quality.'

Specifications for this system will be available soon.

spacer

• View the DATABASE results for 'Imagic' (2).Open this link in a new window.

ImaRx LLCMRI Resource Directory:
 - Manufacturers -
 
www.imarx.com

Founded in 1991, ImaRx Pharmaceutical Corp. designs, develops and markets pharmaceuticals for medical imaging (MRI, ultrasound and computed tomography) for the radiological imaging industry.
ImaRx Pharmaceutical Corp., announced 1999 that it has been acquired by E.I DuPont de Nemours & Co., Inc. The terms of the acquisition provide a royalty-free licensing arrangement with a newly-formed company, ImaRx LLC ("LLC"), to pursue and develop new products and technologies for drug and gene delivery independent from DuPont. Yamanouchi Pharmaceutical Co. Ltd., ImaRx' licensee for Asian territories for this product, will continue to develop the product in Asia as DuPont's licensee. ImaRx LLC will have ownership of all other targeted and therapeutic products previously owned by ImaRx, including imaging products outside of diagnostic ultrasound imaging and two other imaging products, SonoRx® and LumenHance® LumenHance®, which are both FDA approved and licensed to BRACCO Diagnostics.

Ultrasound Related Product Lines:
Contrast Agents:
TRADE NAME FOR SALE FOR SALE /
DEVELOPMENT
DEVELOPMENT
Definity®
SonoRx
MRX 408

Contact Information:
MAIL ImaRx LLC
1635 East 18th Street
Tucson AZ 85719-6803 USA
PHONE +1-520-770-1259
spacer

• View the DATABASE results for 'ImaRx LLC' (4).Open this link in a new window.

US Resources  
Used and Refurbished UltraSound Equipment - General - Hospitals - Pediatric - Service and Repair - Distributors
 
SEARCH FOR   
  12345ABCDEFGHIJKLMNOPQRSTUVWZ
    1 - 5 (of 21)      next 
 iE-Im    Im-In   In-In   In-Is   iU-iU   
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

US-TIP    
Community   
User
Pass
Forgot your UserID/Password ?  


Look
      Ups



UltraSound - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • US-TIP • The-Medical-Market
Copyright © 2006 - 2016 SoftWays. All rights reserved.
Terms of Use | Privacy Policy | Advertising
 [last update: 2015-03-04 09:17:02]